A Multicenter, Parallel-Group, Randomized, 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of 50 mg Of DVS SR In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder
收藏DataCite Commons2025-11-24 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00005347/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
A multicenter, 10-week study to evaluate the efficacy and safety of 50 mg of desvenlafaxine succinate sustained-release formulation (DVS SR) versus placebo in the treatment of peri- and postmenopausal women with major depressive disorder
本研究为一项多中心、为期10周的临床试验，旨在评估50mg琥珀酸去甲文拉法辛缓释制剂（desvenlafaxine succinate sustained-release formulation，DVS SR）与安慰剂在治疗伴重度抑郁症（Major Depressive Disorder）的围绝经期及绝经后女性中的疗效与安全性
提供机构：
Vivli
创建时间：
2020-03-23
